Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial - Concepedia

Concepedia

Publication | Closed Access

Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial

104

Citations

27

References

2012

Year

Claire Higham, A. B. Atkinson, Simon Aylwin, Martin Bidlingmaier, William Drake, A A M Lewis, Niamh Martin, Veronica Moyes, John Newell‐Price, Peter Trainer

The Journal of Clinical Endocrinology & Metabolism

Abstract

These data suggest that combination treatment with cabergoline and pegvisomant is more effective at reducing IGF-I levels than either cabergoline or pegvisomant monotherapy.

References

	Year	Citations

Page 1